CN101884727B - Traditional Chinese medicine for treating rhinitis - Google Patents
Traditional Chinese medicine for treating rhinitis Download PDFInfo
- Publication number
- CN101884727B CN101884727B CN2009100648600A CN200910064860A CN101884727B CN 101884727 B CN101884727 B CN 101884727B CN 2009100648600 A CN2009100648600 A CN 2009100648600A CN 200910064860 A CN200910064860 A CN 200910064860A CN 101884727 B CN101884727 B CN 101884727B
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- chinese medicine
- rhinitis
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating rhinitis, and belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine is characterized by being prepared from the following raw materials in part by weight: 10 to 25 parts of angelica dahurlica, 8 to 20 parts of manchurian wildginger, 10 to 25 parts of biond magnolia flower, 10 to 25 parts of siberian cocklour fruit, 2 to 8 parts of ephedra, 2 to 10 parts of incised notopterygium rhizome, 2 to 10 parts of baical skullcap root, 2 to 10 parts of cortex phellodendri, 2 to 10 parts of honeysuckle, 2 to 8 parts of mint, 2 to 10 parts of szechuan lovage rhizome, 2 to 8 parts of siberian solomonseal rhizome, 2 to 8 parts of India madder root and 2 to 8 parts of cyrtomium fortunei. The traditional Chinese medicine has the obvious curative effects on rhinitis, nasosinusitis, prosopantritis, maxillary sinusitis, hypertrophy of nasal turbinates, allergic rhinitis and symptoms such as headache, dizziness, insomnia, dreaminess, memory decline, runny nose, yellow and thick nasal discharge, sneezing, nasal obstruction, aromatic and smelly ignorance which are caused by the reasons, has the characteristics of good curative effect, quick response, convenient carrying, good mouthfeel, and convenient popularization and use.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of rhinitis, belong to technical field of Chinese medicines.
Background technology
Rhinitis is a kind ofly to be reduced by the intrinsic factor Abwehrkraft des Koepers, disease due to the stimulation of extrinsic factor atmospheric pollution, clinical manifestation is intermittent, alternately property nasal obstruction resistance, and headache, nasal discharge increase sneeze, small amount bleeding is arranged sometimes, especially the northern area of China, winter climate cold, drying all can take place throughout the year, it is just more to suffer from this sick chance, and he gives daily life and the healthy a lot of misery and inconvenient of bringing.
Doctor trained in Western medicine thinks that rhinitis is due to the localized bacterial infection, and main treatment means is that operative treatments such as traditional surgical operation and modern microwave, freezing, cryogenic ablation, puncture are used and continued to use to antibiotic.Antibiotic therapy can only the respite symptom, and life-time service can cause side effect such as nasal mucosa atrophy.The operative treatment medical care expenses is relatively more expensive, and operative treatment easily causes nasal mucosa vessels and neural tissue injury and nasal mucosa disturbance of blood circulation, clinical symptoms is increased the weight of, even cause the untoward reaction such as medicamentous rhinitis that operation sequela and medicine cause because of vasoconstrictive.
The traditional Chinese medical science is thought, rhinitis is many because of wind and cold, wind heat cause, lung-heat, gallbladder-heat, turbid damp, expectorant dirt are the main causes of morbidity, and the patient is every because of wind-cold affecting lung, accumulate and heat-transformation, or experience wind heat, be to cause the gas lung to lose a surname, instability of surface, it is loose to play reason, the heresy of wind and cold avails oneself of the opportunity to get in, and in clear key, and causes the nasal obstruction watery nasal discharge on the exopathogen.After ailment said due to cold or exposure is separated, hot and suffocating unclear, make and be dope, stop up in the nose key, turn to the pus tears, delay and send out rhinitis.
Summary of the invention
Technical problems such as the technical problem to be solved in the present invention is that the existing antibiotic therapy rhinitis that adopts causes the nasal mucosa atrophy easily, and surgical operation expense costliness, side effect are big provide that a kind of cost is low, the Chinese medicine of good effect, treatment rhinitis that toxic and side effects is little.
For solving the problems of the technologies described above, the technical solution used in the present invention is as follows:
The Chinese medicine of treatment rhinitis of the present invention is to be made by the raw material of following parts by weight: 10~25 parts of the Radixs Angelicae Dahuricae, 8~20 parts of Herba Asaris, 10~25 parts of Flos Magnoliaes, 10~25 parts of Fructus Xanthii, 2~8 parts in Herba Ephedrae, 2~10 parts of Rhizoma Et Radix Notopterygiis, 2~10 parts of Radix Scutellariaes, 2~10 parts of Cortex Phellodendris, 2~10 parts of Flos Lonicerae, 2~8 parts of Herba Menthaes (Bu He), 2~10 parts of Rhizoma Chuanxiong, 2~8 parts of Rhizoma Polygonatis, 2~8 parts in Radix Rubiae, 2~8 parts of Rhizoma Osmundae.
The Chinese medicine of treatment rhinitis of the present invention is preferably made by the raw material of following parts by weight: 13~18 parts of the Radixs Angelicae Dahuricae, 10~15 parts of Herba Asaris, 13~18 parts of Flos Magnoliaes, 13~18 parts of Fructus Xanthii, 2~6 parts in Herba Ephedrae, 2~6 parts of Rhizoma Et Radix Notopterygiis, 2~6 parts of Radix Scutellariaes, 4~8 parts of Cortex Phellodendris, 4~8 parts of Flos Lonicerae, 2~6 parts of Herba Menthaes (Bu He), 4~8 parts of Rhizoma Chuanxiong, 2~6 parts of Rhizoma Polygonatis, 2~6 parts in Radix Rubiae, 2~6 parts of Rhizoma Osmundae.
The Chinese medicine of treatment rhinitis of the present invention is preferably made by the raw material of following parts by weight: 16 parts of the Radixs Angelicae Dahuricae, 13 parts of Herba Asaris, 16 parts of Flos Magnoliaes, 16 parts of Fructus Xanthii, 3 parts in Herba Ephedrae, 5 parts of Rhizoma Et Radix Notopterygiis, 5 parts of Radix Scutellariaes, 5 parts of Cortex Phellodendris, 5 parts of Flos Lonicerae, 3 parts of Herba Menthaes (Bu He), 5 parts of Rhizoma Chuanxiong, 3 parts of Rhizoma Polygonatis, 3 parts in Radix Rubiae, 3 parts of Rhizoma Osmundae.
The Chinese medicine production method of above-mentioned treatment rhinitis is: at first Fructus Xanthii, Radix Scutellariae, Cortex Phellodendri, Rhizoma Chuanxiong, Rhizoma Polygonati are obtained Fructus Xanthii (parched), Radix Scutellariae (parched with wine), wine Cortex Phellodendri (parched), wine stir-fry Rhizoma Chuanxiong and Rhizoma Polygonati (steamed) respectively after concocting, then each medicament mixed is processed through milling process, medicine powder is incapsulated, and institute's powder charge thing is 0.4g in each capsule.
Chinese medicine of the present invention can also be made pill.
Among the present invention, Radix Angelicae Dahuricae: main note is sensible, nasal sinusitis pain, eyebrow shuttle osteodynia, the kind all diseases of women's head-ornaments of controlling.Herba Asari: hot Wen Xiang scurries, the heresy of kind energy dispersing wind-cold, and loss of smelling sense is good and foul smells, no sweating.Flos Magnoliae: on lead in nose, be used for cacorhinia more, nasal sinusitis, nasal obstruction, watery nasal discharge are stench.Fructus Xanthii: rhinocleisis, turbid tears do not flow, and are used for headache, nasal sinusitis, the wind syndrome of head headache, nasal sinusitis flows the disease of turbid tears.Rhizoma Et Radix Notopterygii: relieving the exterior syndrome with drugs of pungent in flavor and warm in nature, the headache of pathogenic factor in the exterior plug heat, all over the body to the greatest extent bitterly, the acute rhinitis headache.Herba Ephedrae: relieving the exterior syndrome with drugs of pungent in flavor and warm in nature can stimulate nose to be stained with film.Radix Scutellariae: heat clearing and damp drying, eliminating fire and detoxication.Cortex Phellodendri: heat clearing and damp drying, eliminating fire and detoxication.Flos Lonicerae: heat-clearing and toxic substances removing, antiinflammatory are controlled all toxic swellings.Herba Menthae (Bu He): discongest wind heat, the clear sharp head.Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping.Rhizoma Polygonati: the spleen reinforcing lung moistening, control the disease that insufficiency of lung-QI causes.Radix Rubiae: removing heat from blood, hemostasis promoting the circulation of blood, blood circulation promoting and blood stasis dispelling, the cacorhinia that can prevent recurrence after operation.Rhizoma Osmundae: heat-clearing and toxic substances removing stops blooding, and can strengthen the drag of shaking of cacorhinia, stimulates nose to be stained with film.
Instructions of taking: obey every day three times, each five, eliminating cold for resuscitation water send down.
The invention has the beneficial effects as follows: this medicine is pure Chinese medicine preparation, have no side effect, can treat rhinitis, sinusitis, frontal sinusitis, go up frontal sinusitis, nose cheek hypertrophy, allergic rhinitis, and the rare tears of headache, dizziness, insomnia and dreamful sleep, hypomnesis, stream, stream yellow thick tears, the sneeze that cause of above-mentioned reason, have a stuffy nose, do not know symptoms such as good and foul smells.And the people to easy catching a cold, cacorhinia immunocompromised has played raising effect efficiently, thereby has reached the purpose of treatment and radical cure.
The situation that 200 patients are carried out clinical observation: among the 200 routine patients, women's 126 examples, male's 74 examples, patient's minimal ages 8 years old, at maximum 54 years old age of patient, the course of disease is the shortest 1 year, and the course of disease is the longest 16 years.During treatment, according to age size and the administration course of treatment, patient below 14 years old take medicine at every turn 0.4 the gram, more than 14 years old the patient take medicine at every turn 2 the gram, every day three times, a month course of treatment, avoid tobacco and wine, pungent, raw and cold, greasy food during the treatment.The result is: produce effects 85 examples, and effective 111 examples, invalid 4 examples, total effective rate reaches 98%.
The treatment standard, produce effects: transference cure or part disappearances such as headache, giddy, nasal obstruction, watery nasal discharge, hyposmia, the hyperemia of rhinoscopy nasal mucosa, swelling are replied normal.Effectively: symptoms such as headache, giddy, nasal obstruction, watery nasal discharge, hyposmia are clearly better, and the hyperemia of rhinoscopy nasal mucosa, swelling obviously improve, and follow up a case by regular visits to not recurrence after 1 year.Invalid: symptom and sign no change or variation are slight, rhinoscopy result and the preceding no change of treatment.
The specific embodiment
Below by embodiment the present invention is elaborated, but and do not limit the present invention in any way.
Embodiment 1
Take by weighing raw material by following weight proportion:
14 parts of the Radixs Angelicae Dahuricae, 15 parts of Herba Asaris, 18 parts of Flos Magnoliaes, 14 parts of Fructus Xanthii, 4 parts in Herba Ephedrae, 4 parts of Rhizoma Et Radix Notopterygiis, 5 parts of Radix Scutellariaes, 5 parts of Cortex Phellodendris, 6 parts of Flos Lonicerae, 3 parts of Herba Menthaes (Bu He), 4 parts of Rhizoma Chuanxiong, 3 parts of Rhizoma Polygonatis, 3 parts in Radix Rubiae, 3 parts of Rhizoma Osmundae.Each medicine incapsulates medicine powder through milling process processing, and institute's powder charge thing is 0.4g in each capsule.
Embodiment 2
Take by weighing raw material by following parts by weight:
18 parts of the Radixs Angelicae Dahuricae, 13 parts of Herba Asaris, 14 parts of Flos Magnoliaes, 18 parts of Fructus Xanthii, 3 parts in Herba Ephedrae, 4 parts of Rhizoma Et Radix Notopterygiis, 4 parts of Radix Scutellariaes, 4 parts of Cortex Phellodendris, 5 parts of Flos Lonicerae, 3 parts of Herba Menthaes (Bu He), 4 parts of Rhizoma Chuanxiong, 4 parts of Rhizoma Polygonatis, 3 parts in Radix Rubiae, 4 parts of Rhizoma Osmundae.Each medicine incapsulates medicine powder through milling process processing, and institute's powder charge thing is 0.4g in each capsule.
Embodiment 3:
Take by weighing raw material by following parts by weight:
16 parts of the Radixs Angelicae Dahuricae, 13 parts of Herba Asaris, 16 parts of Flos Magnoliaes, 16 parts of Fructus Xanthii, 3 parts in Herba Ephedrae, 5 parts of Rhizoma Et Radix Notopterygiis, 5 parts of Radix Scutellariaes, 5 parts of Cortex Phellodendris, 5 parts of Flos Lonicerae, 3 parts of Herba Menthaes (Bu He), 5 parts of Rhizoma Chuanxiong, 3 parts of Rhizoma Polygonatis, 3 parts in Radix Rubiae, 3 parts of Rhizoma Osmundae.Each medicine incapsulates medicine powder through milling process processing, and institute's powder charge thing is 0.4g in each capsule.
Model case:
Normal open is kind: the man, 45 years old, the Feng Zhuan of Yanjin County township Hou Tun people from village suffered from rhinitis 3 years, through specially treatment of north, Henan doctor, Chinese medicine of the present invention was taken in the recurrence in back four months of puncturing afterwards, one month one course of treatment, eat three courses of treatment after, nothing had recurrence in 2 years, curative effect is good.
Hu Suigen: the man, 42 years old, big village, Jun Xianxinzhen township Du Hang people from village suffered from rhinitis 2 years, and be repeatedly invalid through the other places treatment, treated to me afterwards, takes Chinese medicine of the present invention, and one month one course of treatment, do not have recurrence is arranged 33 years so far later course of treatment, and curative effect is good.
Chen Wuni: the woman, 36 years old, Jun Xianxinzhen township river in Henan Province door people from village suffered from rhinitis 2 years, failed to respond to any medical treatment through too much place, and seek medical advice to me in the back, and process is taken Chinese medicine of the present invention, and one month one course of treatment, after total 13 bottles of 3 courses of treatment, not having so far has recurrence, and curative effect is good.
Liu Yuzhen: the woman, 54 years old, Jun Xianxinzhen people from village suffered from rhinitis 4 years, repeatedly failed to respond to any medical treatment, and took Chinese medicine of the present invention one month one course of treatment, and one month one course of treatment, 3 courses of treatment, not having so far has recurrence, and curative effect is good.
Claims (3)
1. Chinese medicine for the treatment of rhinitis is characterized in that being being made by the raw material of following parts by weight: 10~25 parts of the Radixs Angelicae Dahuricae, 8~20 parts of Herba Asaris, 10~25 parts of Flos Magnoliaes, 10~25 parts of Fructus Xanthii, 2~8 parts in Herba Ephedrae, 2~10 parts of Rhizoma Et Radix Notopterygiis, 2~10 parts of Radix Scutellariaes, 2~10 parts of Cortex Phellodendris, 2~10 parts of Flos Lonicerae, 2~8 parts of Herba Menthaes, 2~10 parts of Rhizoma Chuanxiong, 2~8 parts of Rhizoma Polygonatis, 2~8 parts in Radix Rubiae, 2~8 parts of Rhizoma Osmundae.
2. the Chinese medicine of treatment rhinitis according to claim 1 is characterized in that being being made by the raw material of following parts by weight: 13~18 parts of the Radixs Angelicae Dahuricae, 10~15 parts of Herba Asaris, 13~18 parts of Flos Magnoliaes, 13~18 parts of Fructus Xanthii, 2~6 parts in Herba Ephedrae, 2~6 parts of Rhizoma Et Radix Notopterygiis, 2~6 parts of Radix Scutellariaes, 4~8 parts of Cortex Phellodendris, 4~8 parts of Flos Lonicerae, 2~6 parts of Herba Menthaes, 4~8 parts of Rhizoma Chuanxiong, 2~6 parts of Rhizoma Polygonatis, 2~6 parts in Radix Rubiae, 2~6 parts of Rhizoma Osmundae.
3. the Chinese medicine of treatment rhinitis according to claim 2 is characterized in that being being made by the raw material of following parts by weight: 16 parts of the Radixs Angelicae Dahuricae, 13 parts of Herba Asaris, 16 parts of Flos Magnoliaes, 16 parts of Fructus Xanthii, 3 parts in Herba Ephedrae, 5 parts of Rhizoma Et Radix Notopterygiis, 5 parts of Radix Scutellariaes, 5 parts of Cortex Phellodendris, 5 parts of Flos Lonicerae, 3 parts of Herba Menthaes, 5 parts of Rhizoma Chuanxiong, 3 parts of Rhizoma Polygonatis, 3 parts in Radix Rubiae, 3 parts of Rhizoma Osmundae.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100648600A CN101884727B (en) | 2009-05-12 | 2009-05-12 | Traditional Chinese medicine for treating rhinitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100648600A CN101884727B (en) | 2009-05-12 | 2009-05-12 | Traditional Chinese medicine for treating rhinitis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101884727A CN101884727A (en) | 2010-11-17 |
CN101884727B true CN101884727B (en) | 2011-11-16 |
Family
ID=43070927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100648600A Expired - Fee Related CN101884727B (en) | 2009-05-12 | 2009-05-12 | Traditional Chinese medicine for treating rhinitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101884727B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102641370A (en) * | 2012-05-02 | 2012-08-22 | 李承平 | Pharmaceutical composition ointment for treating rhinitis |
CN103142785B (en) * | 2013-01-26 | 2015-02-18 | 苏甲臣 | Rhinitis treatment medicine |
CN103550731B (en) * | 2013-10-29 | 2015-09-09 | 金福娥 | A kind of Chinese medicine for the treatment of chronic sinusitis |
CN105031209A (en) * | 2015-07-01 | 2015-11-11 | 兰永海 | Orally-taken traditional Chinese medicine pill capable of eliminating frontal sinusitis and relieving pain and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1879791A (en) * | 2006-04-28 | 2006-12-20 | 白安福 | A nasal drop for treating rhinitis and method for preparing same |
-
2009
- 2009-05-12 CN CN2009100648600A patent/CN101884727B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1879791A (en) * | 2006-04-28 | 2006-12-20 | 白安福 | A nasal drop for treating rhinitis and method for preparing same |
Non-Patent Citations (2)
Title |
---|
刘敬等.中医治疗变应性鼻炎概况.《河北中医》.2007,第29卷(第2期),183-185. * |
李云鹏.过敏性鼻炎中医治疗概况.《甘肃中医学院学报》.2007,第24卷(第4期),49-52. * |
Also Published As
Publication number | Publication date |
---|---|
CN101884727A (en) | 2010-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101156925B (en) | A traditional Chinese medicine preparation for treating children dermatosis | |
CN103230493B (en) | Traditional Chinese medicine composition for treating unhealed wound | |
CN104352587A (en) | Ointment for treating rhinitis | |
CN102266393A (en) | External application medicament for treating allergic rhinitis and preparation method thereof | |
CN103623215B (en) | A kind of Traditional Chinese medicine tea drink for the treatment of chronic pharyngitis | |
CN101884727B (en) | Traditional Chinese medicine for treating rhinitis | |
CN103610776B (en) | A kind of gynecological pudendum nursing cleaning medicinal liquid | |
CN102908474B (en) | Medicinal liquor for treating neurosis | |
CN101721558B (en) | Cough stopping oral liquor for children | |
CN106668631A (en) | Chinese herbal medicine for treating rhinitis | |
CN103223110B (en) | External traditional Chinese medicine composition for treating female pruritus vulvae and preparation method thereof | |
CN104491806A (en) | External traditional Chinese medicine for treating allergic rhinitis | |
CN103845617A (en) | Medicament for treating latent glomerulonephritis | |
CN103720762A (en) | Fumigant for treating rhinitis and preparation method thereof | |
CN103263548A (en) | Embrocation for treating haemorrhoids and application thereof | |
CN101822693A (en) | Medicine treating tympanitis | |
CN102370853A (en) | Traditional Chinese medicine for treating chronic pyelonephritis | |
CN102349984B (en) | External drug for treating beriberi, foot odor and hircismus | |
CN105194165B (en) | Traditional Chinese medicine used for treating infection of urinary system and preparation method thereof | |
CN103341151A (en) | Traditional Chinese medicine for treating chronic bronchitis | |
CN102526570A (en) | Foot bath Chinese medicinal composition for treating cough | |
CN107998367A (en) | A kind of dispersing swelling and dissipating binds stasis-dispelling and pain-killing plaster | |
CN100506248C (en) | Instant acting medicament for treating rhinitis | |
CN105412883A (en) | Traditional Chinese medicine composition for treating chronic bronchitis | |
CN104257875A (en) | Externally-applied traditional Chinese medicine composition for nursing acute mastitis of women |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111116 Termination date: 20170512 |